Erectile Dysfunction (ED) Drugs Market to Reach US$ 2.87 Bn by 2026 End
Erectile dysfunction (ED) is the inability to achieve or maintain an erection sufficiently for satisfactory sexual performance. Aging is a major factor responsible for impeding the normal function of erection. Cardiovascular diseases, diabetes mellitus, spinal cord injuries, and hypertension, medications are some factors that have been found to cause erectile dysfunction. The first line of treatment for ED comprises oral medication of PDE5 inhibitors. The global erectile dysfunction drugs market was valued at US$ 4.35 Bn in 2016 and is...
View full press release